CeQur Company

CeQur SA is dedicated to developing and commercializing advanced insulin delivery systems that make it easier for people living with type 2 diabetes to comply with therapy and stay in control of their disease.

CeQur is developing the CeQur Insulin Infuser, a simple and discrete insulin delivery tool for people who could benefit from intensive insulin therapy but want flexibility and freedom from multiple daily injections.

CeQur was established in January 2008 as a spin out from Danfoss A/S, a large, global Danish industrial products group.
Technology: P4 Medicine
Industry: P4 Medicine
Headquarters: Horw, Luzern, Switzerland
Founded Date: 6-30
Employees Number: 51-100
Funding Status: Late Stage Venture
Investors Number: 6
Total Funding: $156.6M
Estimated Revenue: $1M to $10M
Last Funding Type: Series C

Visit Website
Register and Claim Ownership